These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26550111)

  • 1. Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.
    Liu J; Wang C; Zhao H; Zhang J; Ma J; Hou Y; Zou H
    Int J Clin Exp Med; 2015; 8(8):11985-95. PubMed ID: 26550111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
    Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
    Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
    Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
    Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2875-88. PubMed ID: 24169613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
    Labriola L; Crott R; Jadoul M
    Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.
    Yahav D; Rozen-Zvi B; Gafter-Gvili A; Leibovici L; Gafter U; Paul M
    Clin Infect Dis; 2008 Jul; 47(1):83-93. PubMed ID: 18498236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis.
    Zhang J; Wang B; Li R; Ge L; Chen KH; Tian J
    Int Urol Nephrol; 2017 Apr; 49(4):701-716. PubMed ID: 28035620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
    Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
    Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrated Sodium Citrate (23%) for Catheter Lock.
    Ash SR; Mankus RA; Sutton JM; Criswell RE; Crull CC; Velasquez KA; Smeltzer BD; Ing TS
    Hemodial Int; 2000 Jan; 4(1):22-31. PubMed ID: 28455911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Wang Y; Sun X
    Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-Analysis of Antibiotic and Antimicrobial Lock Solutions for Prevention of Hemodialysis Catheter-Related Infections.
    Abdul Salim S; Masoud AT; Thongprayoon C; Cheungpasitporn W; Soliman KM; Garla V; Sofy AA; Ahmed AS; Abdelsattar AT; Zsom L; Tapolyai M; Fülöp T
    ASAIO J; 2021 Oct; 67(10):1079-1086. PubMed ID: 33587469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis.
    Chapla K; Oza-Gajera BP; Yevzlin AS; Shin JI; Astor BC; Chan MR
    J Vasc Access; 2015; 16(2):107-12. PubMed ID: 25262758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis.
    Kavosi Z; Sarikhani Khorrami M; Keshavarz K; Jafari A; Hashemi Meshkini A; Safaei HR; Nikfar S
    Med J Islam Repub Iran; 2016; 30():347. PubMed ID: 27390716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.